A61P 17 - Drugs for dermatological disorders

Patents for A61P 17 - Drugs for dermatological disorders (106,455)
11/2001
11/08/2001	US20010039038 Novel glucosaminidase
11/08/2001	US20010038843 Immunogenic polypeptide comprising a self Immunoglobin E (IgE) portion and a non-self IgE portion, to induce an anti-self IgE response in a mammal; treating diseases such as allergies
11/08/2001	EP1144348A3 Lta 4? hydrolase inhibitors
11/08/2001	CA2418748A1 3-nitrogen-6,7-dioxygen steroids and uses related thereto
11/08/2001	CA2414296A1 Anti-inflammatory compounds and uses thereof
11/08/2001	CA2414290A1 Anti-inflammatory compounds and uses thereof
11/08/2001	CA2408011A1 Splice-region antisense composition and method
11/08/2001	CA2407965A1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
11/08/2001	CA2407959A1 Human wingless-like gene
11/08/2001	CA2407956A1 Modified peptides as therapeutic agents
11/08/2001	CA2407824A1 Pharmaceutical composition
11/08/2001	CA2407799A1 (2-oxindol-3-ylidenyl)acetic acid derivatives and their use as protein kinase inhibitors
11/08/2001	CA2407797A1 Methods for treatment of diseases associated with inflammation under non-ischemic conditions
11/08/2001	CA2407785A1 Use of .alpha.-msh and epo for preventing or treating ischemic conditions
11/08/2001	CA2407746A1 Proteases
11/08/2001	CA2407399A1 Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy
11/08/2001	CA2407334A1 Lipochroman-6 as no-synthase inhibitor and uses
11/08/2001	CA2407311A1 Plant extract of the species vitis vinifera as no-synthase inhibitor and uses
11/08/2001	CA2407294A1 Plant extract of the olea europaea species as no-synthase inhibitor and uses
11/08/2001	CA2407235A1 Hemostatic compositions of polyacids and polyalkylene oxides and methods for their use
11/08/2001	CA2407189A1 New gamma selective retinoids
11/08/2001	CA2405745A1 New betamimetics having a long-lasting activity, processes for preparingthem and their use as medicaments
11/08/2001	CA2403901A1 29 human secreted proteins
11/07/2001	EP1152055A1 ADAMTS polypeptides, nucleic acids encoding them, and uses therof
11/07/2001	EP1152002A1 Pyrrole derivatives and cell death inhibitors
11/07/2001	EP1151131A1 Process for the preparation of pseudomonic acid a antibiotic by microbiological method
11/07/2001	EP1151129A2 Methods of making compounds
11/07/2001	EP1151101A1 Prostacyclin-stimulating factor-2
11/07/2001	EP1151095A1 Polypeptide variants with raised heparin-binding capacity
11/07/2001	EP1151082A1 Sebocytes, sebocyte cell lines and applications thereof
11/07/2001	EP1151067A1 Process of converting rendered triglyceride oil from marine sources into bland, stable oil
11/07/2001	EP1151012A1 Rhamm antagonist antibodies
11/07/2001	EP1150994A2 Genes displaying enhanced expression during cellular senescence and terminal cell differentiation and uses thereof
11/07/2001	EP1150991A2 Compositions for treating inflammatory response
11/07/2001	EP1150979A1 Heteroaryl amidines, methylamidines and guanidines as protease inhibitors
11/07/2001	EP1150973A1 Heteroaryl-substituted quinolin-2-one derivatives useful as anticancer agents
11/07/2001	EP1150970A1 (1-phenacy-3-phenyl-3-piperidylethyl)piperidine derivatives, method for the production thereof and pharmaceutical compositions containing the same
11/07/2001	EP1150965A1 Benzazepine derivatives as alpha-v integrin receptor antagonists
11/07/2001	EP1150960A1 Polymorphic crystalline forms of celecoxib
11/07/2001	EP1150959A1 Solid-state form of celecoxib having enhanced bioavailability
11/07/2001	EP1150954A1 Anti-imflammatory indole derivatives
11/07/2001	EP1150953A1 Indole derivatives and their use as mcp-1 receptor antagonists
11/07/2001	EP1150950A2 Anthranilic acid derivatives
11/07/2001	EP1150690A1 Chemical compounds
11/07/2001	EP1150689A1 Chemical compounds
11/07/2001	EP1150671A1 Use of pyrethroid compounds to promote hair growth
11/07/2001	EP1150666A1 Stimulating neutrophil function to treat inflammatory bowel disease
11/07/2001	EP1150655A1 Use of nanoscale chitosanes and/or chitosane derivatives
11/07/2001	EP1150652A1 Skin lightening agents
11/07/2001	EP1150564A1 Inositol derivatives for inhibiting superoxide anion production
11/07/2001	EP0949901B1 Cosmetic cleansing and skin care preparation containing plant and algae extracts
11/07/2001	EP0845007B1 Pharmaceutical composition containing inhibitors of interferon-gamma
11/07/2001	EP0765152B1 Stimulation of hair growth by peptide-copper complexes
11/07/2001	EP0751789B1 Gel for treatment of skin diseases and for disinfection of the skin
11/07/2001	EP0600028B1 Use of selective ligands for treatment of disease states responsive to steroid or steroid-like hormones
11/07/2001	CN1321151A Chemical compounds
11/07/2001	CN1321150A Amide derivs. useful as inhibitors of production of cytokines
11/07/2001	CN1321147A Indolin derivs. as sun protection agents
11/07/2001	CN1320443A Face-beautifying chewing gum and its preparing process
11/07/2001	CN1320435A Medicine for treating burn and scald
11/07/2001	CN1320432A Cooling and detoxicating oral liquid and preparing process
11/07/2001	CN1320431A Compound pueraria root tea and preparing process thereof
11/07/2001	CN1320430A Oral liquid for treating ephelides and its preparing process
11/07/2001	CN1320422A Process for preparing Chinese-medicinal pills containing borneol
11/06/2001	US6313312 3-Azabicyclo[3.1.0]hexane derivatives useful in therapy
11/06/2001	US6313270 DbpB
11/06/2001	US6313174 Aminobenzophenones as inhibitors of interleukin and TNF
11/06/2001	US6313163 Administering 2,4-pentadienoic acid derivative for therapy of disease or condition responsive to therapy by retinoids
11/06/2001	US6313162 Propynyl or dienyl biaromatic compounds
11/06/2001	US6313156 Thiazole compounds as cyclic-AMP-specific phosphodiesterase inhibitors
11/06/2001	US6313129 Therapeutic compounds
11/06/2001	US6313128 Can be used as lypolysis/lypogenesis regulators in the skin without, interferring with the skin's natural functions; for therapy of saborrhea and acne
11/06/2001	US6313117 Succinate derivative compounds useful as cysteine protease inhibitors
11/06/2001	US6313116 Phosphodiesterase inhibitors
11/06/2001	US6313107 Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI
11/06/2001	US6312923 Method for expression of heterologous proteins in yeast
11/06/2001	US6312663 Prediction of diabetes impaired wound healing by urinary nitrate assay
11/01/2001	WO2001081590A2 Protein phosphatases
11/01/2001	WO2001081585A2 A thymus expressed human cytochrome p450 (p450tec)
11/01/2001	WO2001081581A2 Compositions and methods for the therapy and diagnosis of acne vulgaris
11/01/2001	WO2001081562A1 Novel insulin/igf/relaxin family polypeptides and dnas thereof
11/01/2001	WO2001081540A2 Growth factor which acts through erb b-4 rtk
11/01/2001	WO2001081415A2 Parathyroid hormone and parathyroid hormone-related protein antagonists
11/01/2001	WO2001081363A1 Novel compounds
11/01/2001	WO2001081348A1 USE OF 5-THIO-, SULFINYL- AND SULFONYLPYRAZOLO[3,4-b]-PYRIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS
11/01/2001	WO2001081346A2 Inhibitors of human phosphatidyl-inositol 3-kinase delta
11/01/2001	WO2001081344A1 Salts of bicyclic, n-acylated imidazo-3-amines and imidazo-5-amines
11/01/2001	WO2001081342A2 Novel epothilone derivatives, method for the preparation thereof and their pharmaceutical use
11/01/2001	WO2001081323A1 Benzoxazine and benzothiazine derivatives and the use thereof in medicaments
11/01/2001	WO2001081316A2 Substituted phenyl farnesyltransferase inhibitors
11/01/2001	WO2001081312A2 Method of treatment using phenyl and biaryl derivatives as prostaglandin e inhibitors and compounds useful therefore
11/01/2001	WO2001081311A1 Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis
11/01/2001	WO2001081310A1 1-aroyl-piperidinyl benzamidines
11/01/2001	WO2001081295A1 Cyclohexylamine derivative as subtype selective nmda receptor antagonists
11/01/2001	WO2001080920A2 Antimicrobial bioabsorbable materials
11/01/2001	WO2001080850A1 Urea-containing gel preparation
11/01/2001	WO2001080823A2 Composition exhibiting enhanced formulation stability and delivery of tropical active ingredients
11/01/2001	WO2001080819A1 Cosmetic or dermatological cream composition, the preparation and the use thereof
11/01/2001	WO2001080813A2 Methods for preventing and treating alopecia induced by chemotherapy or radiotherapy
11/01/2001	WO2001080810A2 Chondroitin synthase gene and methods of making and using same

1 ... 851 852 853 854 855 856 857 858 859 860 861 862 863 864 865 866 867 868 869 870 871 ... 1065